POLY MEDICURE
|
POLY MEDICURE Last 5 Year Cashflow Statement History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Profit Before Tax | ₹344 Cr | ₹237 Cr | ₹195 Cr | ₹180 Cr | ₹126 Cr |
Adjustment | ₹37 Cr | ₹61 Cr | ₹39 Cr | ₹44 Cr | ₹51 Cr |
Changes In working Capital | ₹-41 Cr | ₹-49 Cr | ₹-63 Cr | ₹-61 Cr | ₹-12 Cr |
Cash Flow after changes in Working Capital | ₹340 Cr | ₹249 Cr | ₹171 Cr | ₹163 Cr | ₹164 Cr |
Cash Flow from Operating Activities | ₹266 Cr | ₹191 Cr | ₹123 Cr | ₹119 Cr | ₹128 Cr |
Cash Flow from Investing Activities | ₹-241 Cr | ₹-179 Cr | ₹-85 Cr | ₹-436 Cr | ₹-107 Cr |
Cash Flow from Financing Activities | ₹-20 Cr | ₹-13 Cr | ₹-35 Cr | ₹317 Cr | ₹-21 Cr |
Net Cash Inflow / Outflow | ₹4.99 Cr | ₹-0.70 Cr | ₹2.80 Cr | ₹0.10 Cr | ₹0.54 Cr |
Opening Cash & Cash Equivalents | ₹7.06 Cr | ₹7.76 Cr | ₹4.95 Cr | ₹4.86 Cr | ₹4.32 Cr |
Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | - | - |
Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - | - | - |
Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
Effect of Foreign Exchange Fluctuations | - | - | - | - | - |
Closing Cash & Cash Equivalent | ₹12 Cr | ₹7.06 Cr | ₹7.76 Cr | ₹4.95 Cr | ₹4.86 Cr |
Compare Cashflow Statement of peers of POLY MEDICURE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
POLY MEDICURE | ₹21,797.7 Cr | -3% | 3.6% | 41.5% | Stock Analytics | |
NURECA | ₹220.8 Cr | 0.4% | -15.1% | -22.1% | Stock Analytics |
POLY MEDICURE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
POLY MEDICURE | -3% |
3.6% |
41.5% |
SENSEX | -2.5% |
1.9% |
4.9% |
You may also like the below Video Courses